These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 13679151)
1. Roles of MGMT and MLH1 proteins in alkylation-induced apoptosis and mutagenesis. Takagi Y; Takahashi M; Sanada M; Ito R; Yamaizumi M; Sekiguchi M DNA Repair (Amst); 2003 Oct; 2(10):1135-46. PubMed ID: 13679151 [TBL] [Abstract][Full Text] [Related]
2. A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice. Kawate H; Itoh R; Sakumi K; Nakabeppu Y; Tsuzuki T; Ide F; Ishikawa T; Noda T; Nawata H; Sekiguchi M Carcinogenesis; 2000 Feb; 21(2):301-5. PubMed ID: 10657972 [TBL] [Abstract][Full Text] [Related]
3. Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes. Kawate H; Sakumi K; Tsuzuki T; Nakatsuru Y; Ishikawa T; Takahashi S; Takano H; Noda T; Sekiguchi M Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5116-20. PubMed ID: 9560238 [TBL] [Abstract][Full Text] [Related]
4. Killing and mutagenic actions of dacarbazine, a chemotherapeutic alkylating agent, on human and mouse cells: effects of Mgmt and Mlh1 mutations. Sanada M; Takagi Y; Ito R; Sekiguchi M DNA Repair (Amst); 2004 Apr; 3(4):413-20. PubMed ID: 15010317 [TBL] [Abstract][Full Text] [Related]
5. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea. Allay E; Veigl M; Gerson SL Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687 [TBL] [Abstract][Full Text] [Related]
6. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents. Christmann M; Kaina B J Biol Chem; 2000 Nov; 275(46):36256-62. PubMed ID: 10954713 [TBL] [Abstract][Full Text] [Related]
7. A novel protein, MAPO1, that functions in apoptosis triggered by O6-methylguanine mispair in DNA. Komori K; Takagi Y; Sanada M; Lim TH; Nakatsu Y; Tsuzuki T; Sekiguchi M; Hidaka M Oncogene; 2009 Feb; 28(8):1142-50. PubMed ID: 19137017 [TBL] [Abstract][Full Text] [Related]
8. Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest. Sato K; Kitajima Y; Kohya N; Miyoshi A; Koga Y; Miyazaki K Int J Oncol; 2005 Jun; 26(6):1653-61. PubMed ID: 15870882 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer. Liu L; Schwartz S; Davis BM; Gerson SL Cancer Res; 2002 Jun; 62(11):3070-6. PubMed ID: 12036916 [TBL] [Abstract][Full Text] [Related]
10. MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea. McDaid JR; Loughery J; Dunne P; Boyer JC; Downes CS; Farber RA; Walsh CP Br J Cancer; 2009 Aug; 101(3):441-51. PubMed ID: 19623177 [TBL] [Abstract][Full Text] [Related]
11. Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents. Kaina B; Fritz G; Mitra S; Coquerelle T Carcinogenesis; 1991 Oct; 12(10):1857-67. PubMed ID: 1657427 [TBL] [Abstract][Full Text] [Related]
12. MGMT expression in murine bone marrow is a major determinant of animal survival after alkylating agent exposure. Reese JS; Qin X; Ballas CB; Sekiguchi M; Gerson SL J Hematother Stem Cell Res; 2001 Feb; 10(1):115-23. PubMed ID: 11276365 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic and mutagenic effects of methylnitrosourea in two human fetal fibroblast strains differing in O6-methylguanine-DNA methyltransferase activity. Mirzayans R; Middlestadt MV; Paterson MC Carcinogenesis; 1992 Jul; 13(7):1185-90. PubMed ID: 1638685 [TBL] [Abstract][Full Text] [Related]
14. Proteolysis of the mismatch repair protein MLH1 by caspase-3 promotes DNA damage-induced apoptosis. Chen F; Arseven OK; Cryns VL J Biol Chem; 2004 Jun; 279(26):27542-8. PubMed ID: 15087450 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis and mutation in the murine small intestine: loss of Mlh1- and Pms2-dependent apoptosis leads to increased mutation in vivo. Sansom OJ; Bishop SM; Court H; Dudley S; Liskay RM; Clarke AR DNA Repair (Amst); 2003 Sep; 2(9):1029-39. PubMed ID: 12967659 [TBL] [Abstract][Full Text] [Related]
16. Different initial steps of apoptosis induced by two types of antineoplastic drugs. Takagi Y; Hidaka M; Sanada M; Yoshida H; Sekiguchi M Biochem Pharmacol; 2008 Aug; 76(3):303-11. PubMed ID: 18573489 [TBL] [Abstract][Full Text] [Related]
17. Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis. Qin X; Zhou H; Liu L; Gerson SL Carcinogenesis; 1999 Sep; 20(9):1667-73. PubMed ID: 10469609 [TBL] [Abstract][Full Text] [Related]
18. Alkylation-induced apoptosis of embryonic stem cells in which the gene for DNA-repair, methyltransferase, had been disrupted by gene targeting. Tominaga Y; Tsuzuki T; Shiraishi A; Kawate H; Sekiguchi M Carcinogenesis; 1997 May; 18(5):889-96. PubMed ID: 9163672 [TBL] [Abstract][Full Text] [Related]
19. Modulation of Thongararm P; Fedeles BI; Khumsubdee S; Armijo AL; Kim L; Thiantanawat A; Promvijit J; Navasumrit P; Ruchirawat M; Croy RG; Essigmann JM Chem Res Toxicol; 2020 Feb; 33(2):625-633. PubMed ID: 31841318 [TBL] [Abstract][Full Text] [Related]
20. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. Kaina B; Christmann M; Naumann S; Roos WP DNA Repair (Amst); 2007 Aug; 6(8):1079-99. PubMed ID: 17485253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]